Wills S. Klein

Initial Public Offerings 

• Warburg Pincus Capital Corporation I—A and Warburg Pincus Capital Corporation I—B, both special purpose acquisition companies sponsored by affiliates of Warburg Pincus, in connection with the concurrent pricings of their initial public offerings for an aggregate amount of approximately $800 million 
• Slam Corp., a special purpose acquisition company sponsored by affiliates of A-Rod Corp and Antara Capital, in its $575 million initial public offering 
• Kernel Group Holdings, Inc., a special purpose acquisition company, in its $265 million initial public offering  
• Health Assurance Acquisition Corp., a special purpose acquisition company sponsored by an affiliate of General Catalyst, in its $500 million initial public offering of SAIL℠ securities
• Cerberus Telecom Acquisition Corp., a special purpose acquisition company sponsored by an affiliate of Cerberus Capital Management, in its $250 million initial public offering
• Executive Network Partnering Corp., a special purpose acquisition company sponsored by former House Speaker Paul Ryan, Solamere Capital and Alex Dunn, in its $250 million initial public offering of CAPS™
• Periphas Capital Partnering Corp., a special purpose acquisition company, in its $360 million initial public offering of CAPS™
• Montes Archimedes Acquisition Corp., a special purpose acquisition company, in its $400 million initial public offering
• L&F Acquisition Corp., a special purpose acquisition company sponsored by Jeffrey C. Hammes, Adam Gerchen and Victory Park Capital Advisors, in its over $170 million initial public offering
• Cantor Fitzgerald & Co. in the $500 million initial public offering of Atlas Crest Investment Corp.
• Cantor Fitzgerald & Co. in the $300 million initial public offering of Atlas Crest Investment Corp. II 
• Barclays Capital Inc. in the $215 million initial public offering of Rice Acquisition Corp.
• Health Sciences Acquisitions Corporation, a special purpose acquisition company, in its $100 million initial public offering and $480 million combination with Immunovant Sciences Ltd.*
• Chardan Healthcare Acquisition Corp., a special purpose acquisition company, in its $70 million initial public offering and $250 million combination with BiomX, Ltd.*
• Chardan Healthcare Acquisition 2 Corp., a special purpose acquisition company, in its $85 million initial public offering*
• Roth CH Acquisition I Co., a special purpose acquisition company, in its $75 million initial public offering*
• 8i Enterprises Acquisition Corp., a special purpose acquisition company, in its $50 million initial public offering*
• Mountain Crest Acquisition Corp., a special purpose acquisition company, in its $50 million initial public offering*
• Newborn Acquisition Corp., a special purpose acquisition company, in its $50 million initial public offering*

Mergers and Acquisitions

• Montes Archimedes Acquisition Corp. in its combination with Roivant Sciences, and concurrent common equity private placement 
• Tailwind Acquisition Corp. in its proposed $1.4 billion combination with QOMPLX, and concurrent $180 million common equity private placement 
• Oaktree Acquisition Corp. in its $1.6 billion combination with Hims, Inc., a market leading telehealth company, and concurrent $75 million common equity private placement